EUVIMEDEUVIMED entdecken
Open Access

Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood

Olli Raitakari iD, Noora Kartiosuo, Katja Pahkala, Nina Hutri-Kähönen, Lydia A Bazzano iD, Wei Chen iD, Elaine M Urbina iD, David R Jacobs iD, Alan Sinaiko iD, Julia Steinberger, Trudy Burns, Stephen R Daniels und 5 weitere

Circulation · 03.01.2023 · 147 (1) · 23-31

DOI: 10.1161/circulationaha.122.060667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 03.01.2023. Verfasst von Olli Raitakari und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Population Health Research, University of Turku and Turku University Hospital, Finland (O.R., N.K., K.P.). Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated lipoprotein(a) [Lp(a)] is a common risk factor for cardiovascular disease outcomes with unknown mechanisms. We examined its potential role in identifying youths who are at increased risk of developing adult atherosclerotic cardiovascular disease (ASCVD).

Methods

Lp(a) levels measured in youth 9 to 24 years of age were linked to adult ASCVD and carotid intima-media thickness in the YFS (Cardiovascular Risk in Young Finns Study), in which 95 of the original 3596 participants (2.7%) recruited as children have been diagnosed with ASCVD at a median of 47 years of age. Results observed in YFS were replicated with the use of data for White participants from the BHS (Bogalusa Heart Study). In BHS, 587 White individuals had data on youth Lp(a) (measured at 8–17 years of age) and information on adult events, including 15 cases and 572 noncases. Analyses were performed with the use of Cox proportional hazard regression.

Results

In YFS, those who had been exposed to high Lp(a) level in youth [defined as Lp(a) ≥30 mg/dL] had ≈2 times greater risk of developing adult ASCVD compared with nonexposed individuals (hazard ratio, 2.0 [95% CI, 1.4–2.6]). Youth risk factors, including Lp(a), low-density lipoprotein cholesterol, body mass index, and smoking, were all independently associated with higher risk. In BHS, in an age- and sex-adjusted model, White individuals who had been exposed to high Lp(a) had 2.5 times greater risk (95% CI, 0.9–6.8) of developing adult ASCVD compared with nonexposed individuals. When also adjusted for low-density lipoprotein cholesterol and body mass index, the risk associated with high Lp(a) remained unchanged (hazard ratio, 2.4 [95% CI, 0.8–7.3]). In a multivariable model for pooled data, individuals exposed to high Lp(a) had 2.0 times greater risk (95% CI, 1.0–3.7) of developing adult ASCVD compared with nonexposed individuals. No association was detected between youth Lp(a) and adult carotid artery thickness in either cohort or pooled data.

Conclusions

Elevated Lp(a) level identified in youth is a risk factor for adult atherosclerotic cardiovascular outcomes but not for increased carotid intima-media thickness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtherosclerosisAdultChildHumansAdolescentLipoprotein(a)Carotid Intima-Media ThicknessRisk AssessmentRisk FactorsCholesterol, LDL

Stichwörter der Autor:innen

atherosclerosisepidemiologylipoproteinslongitudinal studiesrisk assessmentrisk factors

Substanzen

Lipoprotein(a)Cholesterol, LDL

Autor:innen und Institutionen

  • Centre for Population Health Research, University of Turku and Turku University Hospital, Finland (O.R., N.K., K.P.).
  • Research Centre of Applied and Preventive Cardiovascular Medicine (O.R., N.K., K.P.), University of Turku, Finland.
  • Department of Clinical Physiology and Nuclear Medicine (O.R.), Turku University Hospital, Finland.
  • Paavo Nurmi Centre and Unit for Health and Physical Activity (K.P.), University of Turku, Finland.
  • Tampere Centre for Skills Training and Simulation, Tampere University, Finland (N.H.-K.).
  • Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (L.A.B., W.C.).

ORCID-Profile: Olli Raitakari, Lydia A Bazzano, Wei Chen, Elaine M Urbina, David R Jacobs, Alan Sinaiko, Alison Venn, Jessica G Woo, Terry Dwyer, Markus Juonala, Jorma Viikari

Förderung

  • NICHD NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • NIEHS NIH HHS

Zitieren

APA

Raitakari, O., Kartiosuo, N., Pahkala, K., Hutri-Kähönen, N., Bazzano, L. A., Chen, W., Urbina, E. M., Jacobs, D. R., Sinaiko, A., Steinberger, J., Burns, T., Daniels, S. R., Venn, A., Woo, J. G., Dwyer, T., Juonala, M., & Viikari, J. (2023). Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood. Circulation, 147(1), 23-31. https://doi.org/10.1161/circulationaha.122.060667

Vancouver

Raitakari O, Kartiosuo N, Pahkala K, Hutri-Kähönen N, Bazzano LA, Chen W, et al. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood. Circulation. 2023;147(1):23-31. doi:10.1161/circulationaha.122.060667

BibTeX
@article{Raitakari2023,
  author = {Raitakari, Olli and Kartiosuo, Noora and Pahkala, Katja and Hutri-Kähönen, Nina and Bazzano, Lydia A and Chen, Wei and Urbina, Elaine M and Jacobs, David R and Sinaiko, Alan and Steinberger, Julia and Burns, Trudy and Daniels, Stephen R and Venn, Alison and Woo, Jessica G and Dwyer, Terry and Juonala, Markus and Viikari, Jorma},
  title = {Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {1},
  pages = {23--31},
  doi = {10.1161/circulationaha.122.060667}
}
Kostenlos starten →